E2F1 and retinoblastoma: Based on the aforementioned findings, we subsequently concluded that silencing ANRIL suppresses cell proliferation, cell invasion ability, while acting to promote the apoptosis of retinoblastoma cells with a possible involvement of the ATM-E2F1 signaling pathway.